Advertisement
Screener

Caribou Biosciences, Inc. (CRBU) Net Margin

Caribou Biosciences, Inc. (CRBU) Net Margin

  • 2026-06-30: Net Margin -1619.88%.
  • 2026-03-31: Net Margin -1046.52%.
  • 2025-12-31: Net Margin -672.11%.
  • 2025-09-30: Net Margin -1253.32%.

Complete source-backed net margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1619.88%
2026-03-31-1046.52%
2025-12-31-672.11%
2025-09-30-1253.32%
2025-06-30-2028.42%
2025-03-31-1699.58%
2024-12-31-1708.71%
2024-09-30-1713.64%
2024-06-30-1088.25%
2024-03-31-1697.57%
2023-12-31-969.79%
2023-09-30-42.27%
2023-06-30-786.13%
2023-03-31-800.80%
2022-12-31-731.01%
2022-09-30-806.75%
2022-06-30-636.86%
2022-03-31-716.52%
2021-12-31-722.12%
2021-09-30-527.38%
2021-06-30-969.58%
2021-03-31-829.70%
2020-12-31-1494.21%
2020-09-30-662.19%
2020-06-30-22.08%

Annual Net Margin

DateNet Margin
2025-12-31-1327.40%
2024-12-31-1491.95%
2023-12-31-296.05%
2022-12-31-717.79%
2021-12-31-697.26%
2020-12-31-277.55%
2019-12-31-404.82%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22